Remove 2020 Remove Article Remove Documentation
article thumbnail

Study Reveals Gaps in GINA Guideline Adherence for Asthma Treatment

Pharmacy Times

Pulmonary function tests and provider documentation were manually reviewed to confirm asthma diagnoses, while individuals with other pulmonary diseases were excluded. 1 The study also observed that 65% of patients had a documented visit with an asthma specialist during the follow-up period. 2019;380:2020-2030. N Engl J Med.

article thumbnail

Obesity Medication Use Remains Low Among Children | ADA 2025

Drug Topics

from 2017 to 2020. image credit: syahrir / stock.adobe.com While data shows that obesity has been on the rise among children in recent history, the overall complications spurred on by childhood obesity have been well documented. . Dispensing of glucagon-like peptide-1 receptor agonists to adolescents and young adults, 2020-2023.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

FDA Approves Sebetralstat for Hereditary Angioedema

Drug Topics

The study cohort included 136 patients with a confirmed HAE type 1 or 2 diagnosis who had at least 2 documented HAE attacks within 3 months prior to screening. FDA Approves Nitisinone for Treatment of Alkaptonuria Ashley Gallagher June 19th 2025 Article Alkaptonuria affects approximately 1 in 250,000 to 1 million people in the United States.

FDA 315
article thumbnail

How AI Brings Pharmacogenetics to the Frontline of Precision Medicine

Pharmacy Times

While the European Medicines Agency mandated pre-treatment DPD testing in Europe as early as 2020, and the UK’s National Health Service followed suit the same year, the US only reached a consensus in 2025. Real-World Evidence, Emerging Therapies, and Demonstrating Value Technological advances are accelerating this progress. link] NHS England.

article thumbnail

Breaking New Ground in Migraine Prevention: Eptinezumab-jjmr

Pharmacy Times

On February 21, 2020, the FDA approved eptinezumab-jjmr (Vyepti; Lundbeck) as the first intravenous migraine preventative treatment for adults. They can collect documentation on prior preventive therapies, baseline MMDs, and follow-up outcomes to support prior authorization, including site-of-care arrangements.

article thumbnail

Pharmaceutical Compounding Calculations, Part Two–Bulk Drugs

PharmTech

Thakar Varanya Chaiyaperm View All News Article Bulk drug calculations for different types of active moieties and drugs require different calculations and labeling. It builds on drug calculations topics previously described (1), including guidance documents (2–5). Pluta Nishant B. Pharmaceutical Compounding Calculations. Sutariya, V.;

article thumbnail

CDC Report Finds No Connection Between Thimerosal and Autism

Drug Topics

The properties of thimerosal were documented to contribute to the safe use of multidose vials and packaging of vaccines, such as seasonal and pandemic influenza vaccines. In a new CDC report, investigators found that there was no connection between thimerosal in vaccines and autism or other neurodevelopmental conditions. January 15, 2025.

Vaccines 387